This educational symposium will update the medical community on the state-of-the-art care of gastric and soft tissue neoplasms, while focusing on the importance of a multidisciplinary approach to the diagnosis and treatment of these rare and complicated disease entities; including gastric adenocarcinoma and retroperitoneal soft tissue sarcoma. National and international renowned guest speakers and distinguished faculty, including those from MedStar Health and the Georgetown Lombardi Comprehensive Cancer Center, will discuss the significant roles of evolving new diagnostic modalities, immune therapies, the use of organ-sparing surgery, the use of state-of-the-art radiotherapy in gastric cancer and retroperitoneal sarcomas.
After completing this activity, the participant will be able to;
Identifiy the radiographic and histopathologic features of the different gastric neoplasms
Discuss the diagnostic and therapeutic role of endoscopy in early gastric cancer
Recognize the importance of molecular markers in the diagnosis and treatment of gastric neoplasms
Identify novel targeted and immune therapies for advanced gastric cancer and retroperitoneal sarcomas
Recognize the indications for various targeted therapies for gastric neoplasms
Implement informed therapeutic decision making in the treatment of various types of gastric neoplasms
Discuss the role of radiotherapy for primary and recurrent retroperitoneal sarcomas
Advanced Practice Clinicians $75
Allied Health Professional $75
Cancellations made in writing by August 11, 2017 will be subject to a 50% penalty. No refunds will be given after August 11, 2017. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, MedStar Health will refund the registration fee, but is not responsible for any travel costs.
Please call 202-780-1656 or email [email protected] if you any questions or need any additional information.